Status:

COMPLETED

Impact of Hypoxia on Resting and Exertional Right Ventricular Performance

Lead Sponsor:

University of Colorado, Denver

Conditions:

Ventricular Dysfunction, Right

Hypoxia

Eligibility:

All Genders

18-60 years

Brief Summary

The purpose of this study is to better understand how hypoxia (low oxygen) affects resting and exertional right ventricular function in healthy individuals.

Detailed Description

The right ventricle plays a critical role in exercise. As workload increases with exercise, the right ventricle augments contractility and lusitropy (diastolic relaxation) to accommodate increased ven...

Eligibility Criteria

Inclusion

  • Age 18 - 60
  • For women, premenopausal status

Exclusion

  • Active cardiovascular or pulmonary disease (e.g. hypertension, coronary artery disease, cardiomyopathy, arrhythmia, valvular abnormalities, diabetes, peripheral vascular disease, tobacco use, chronic obstructive pulmonary disease, asthma, interstitial lung disease, restrictive lung disease, or pulmonary hypertension)
  • Use of cardiac- or pulmonary-related medications
  • Prior history of high altitude pulmonary edema or high altitude cerebral edema
  • Body mass index \< 18.5 or \> 30
  • Anemia
  • Iron deficiency
  • Iron supplementation (oral or intravenous) in the preceding 60 days
  • Systemic anticoagulation or aspirin use that cannot be temporarily held for the study
  • Pregnancy
  • Non-cardiopulmonary disorders that adversely influence exercise ability (e.g. arthritis or peripheral vascular disease)
  • Dedicated athletic training (defined here as spending \>9 hours per week in vigorous physical activity \[≥6 mets\])
  • Regular high-altitude exercise (defined here as engaging in vigorous physical activity \[≥1 hour at ≥6 mets\] at ≥8,000 ft for \>2 days per week over the preceding 4 weeks)
  • Residence at ≥8,000 ft for 3 or more consecutive nights in the preceding 30 days

Key Trial Info

Start Date :

April 15 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 15 2022

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT05272514

Start Date

April 15 2022

End Date

December 15 2022

Last Update

May 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States, 80045